Drug Access News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Drug access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Drug Access Today - Breaking & Trending Today
/PRNewswire/ RazorMetrics, a healthcare technology company focused on lowering drug costs for health plans and self-funded employers, released their annual. ....
A government-appointed panel is considering allowing commonly used cough and cold medicines, antacids, and fever-reducing drugs to be sold over the counter (OTC) at general stores in India. While countries like Britain, the US, and Australia have clear guidelines for OTC drug sale, India lacks such regulations. In 2022, India approved a new OTC drug policy, but it was not implemented. ....
Families with workplace health insurance may have missed out on $125,000 in earnings over the past 3 decades due to rising premiums; so far, there have been about 600 drug price hikes in January; experts worry that minority and low-income people will not have easy access to zuranolone, the first FDA-approved postpartum depression pill. ....
David Fajgenbaum, MD, MBA, MSc, cofounder of Every Cure, shared that the organization is able to reduce clinical trial costs to $1 to $5 million per drug trial, and that clinical trials are not always necessary to expand a drug's indication. ....
NCPA presented at a health seminar on “Prescription Drug Access and Costs,” hosted by the National Conference of State Legislatures in Chicago and attended by state legislators with health care and insurance committee responsibilities. (NCSL maintains a database of prescription drug state bills that you might be interested to browse.) NCPA’s presentation focused on PBM vertical integration and the need for state anti-patient steering legislation. ....